About phospholip ids
Pulmonary surfactant replacement
Used for
- Treats respiratory distress syndrome in premature newborns caused by insufficient lung surfactant.
Usual dose in children
Newborns: 100 mg/kg into the lungs; doses may be repeated every 6 hours, up to four total doses.
Common side effects
- Slow heart rate
- Low blood pressure
- Low blood oxygen
- Airway blockage or reflux during administration
Important warnings
- Given directly into the lungs through an endotracheal tube by trained clinicians.
- Breathing and oxygen levels require close monitoring during and after treatment.
- May need adjustment of ventilator settings as lung function improves.
Pregnancy
Not applicable; used to treat newborns after birth.
Breastfeeding
Not applicable; administered directly to newborn lungs.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.